Juan Jesús
Gómez-Reino Carnota
Hospital Universitario de la Princesa
Madrid, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario de la Princesa (21)
2019
-
Specific Association of HLA–DRB1*03 With Anti–Carbamylated Protein Antibodies in Patients With Rheumatoid Arthritis
Arthritis and Rheumatology, Vol. 71, Núm. 3, pp. 331-339
2018
-
Persistence and adverse events of biological treatment in adult patients with juvenile idiopathic arthritis: Results from BIOBADASER
Arthritis Research and Therapy, Vol. 20, Núm. 1
-
Replication study of polymorphisms associated with response to methotrexate in patients with rheumatoid arthritis
Scientific Reports, Vol. 8, Núm. 1
2016
-
Anti-citrullinated peptide antibodies and their value for predicting responses to biologic agents: a review
Rheumatology International, Vol. 36, Núm. 8, pp. 1043-1063
-
Independent candidate serum protein biomarkers of response to adalimumab and to infliximab in rheumatoid arthritis: An exploratory study
PLoS ONE, Vol. 11, Núm. 4
2015
-
Actualización 2014 del Documento de Consenso de la Sociedad Española de Reumatología sobre el uso de terapias biológicas en la artritis reumatoide
Reumatologia Clinica, Vol. 11, Núm. 5, pp. 279-294
2014
-
Documento práctico para el uso de abatacept subcutáneo
Reumatologia Clinica, Vol. 10, Núm. 4, pp. 218-226
-
Health-related quality of life in psoriatic arthritis patients in Spain
Reumatologia Clinica, Vol. 10, Núm. 1, pp. 25-31
-
Lack of replication of interactions between polymorphisms in rheumatoid arthritis susceptibility: Case-control study
Arthritis Research and Therapy, Vol. 16, Núm. 1
2012
-
Discovery of serum proteomic biomarkers for prediction of response to infliximab (a monoclonal anti-TNF antibody) treatment in rheumatoid arthritis: An exploratory analysis
Journal of Proteomics, Vol. 77, pp. 372-382
2011
-
Demyelinating Disease in Patients Treated with TNF Antagonists in Rheumatology: Data from BIOBADASER, a Pharmacovigilance Database, and a Systematic Review
Seminars in Arthritis and Rheumatism, Vol. 40, Núm. 4, pp. 330-337
-
Demyelinating Disease in Patients Treated with TNF Antagonists in Rheumatology: Data from BIOBADASER, a Pharmacovigilance Database, and a Systematic Review
Seminars in Arthritis and Rheumatism, Vol. 41, Núm. 3, pp. 524-533
2010
-
Incidence and risk of hospitalisation due to shingles and chickenpox in patients with rheumatic diseases treated with TNF antagonists
Annals of the Rheumatic Diseases, Vol. 69, Núm. 10, pp. 1751-1755
-
Patient perceptions concerning pain management in the treatment of rheumatoid arthritis
Journal of International Medical Research, Vol. 38, Núm. 4, pp. 1213-1224
-
Recommendations for the management of influenza A (H1N1) in rheumatic patients with immunosuppression
Reumatologia Clinica, Vol. 6, Núm. 1, pp. 63-68
2009
-
Analysis of TNFAIP3, a feedback inhibitor of nuclear factor-κB and the neighbor intergenic 6q23 region in rheumatoid arthritis susceptibility
Arthritis Research and Therapy, Vol. 11, Núm. 2
-
Genetic variation in the nuclear factor κB pathway in relation to susceptibility to rheumatoid arthritis
Annals of the Rheumatic Diseases, Vol. 68, Núm. 4, pp. 579-583
-
Lack of association with rheumatoid arthritis of selected polymorphisms in 4 candidate genes: CFH, CD209, Eotaxin-3, and MHC2TA
Journal of Rheumatology, Vol. 36, Núm. 8, pp. 1590-1595
-
Rheumatoid arthritis does not share most of the newly identified systemic lupus erythematosus genetic factors
Arthritis and Rheumatism, Vol. 60, Núm. 9, pp. 2558-2564
2008
-
Association of interferon regulatory factor 5 haplotypes, similar to that found in systemic lupus erythematosus, in a large subgroup of patients with rheumatoid arthritis
Arthritis and Rheumatism, Vol. 58, Núm. 5, pp. 1264-1274